-
Electronic (PDF)
-
Site License
-
Enterprisewide
Emisphere Technologies, Inc. (EMIS) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2013, Pages: 44
Summary
Emisphere Technologies, Inc. (Emisphere) is a bio pharmaceutical company that focuses on enhanced delivery and absorption of therapeutic molecules and pharmaceutical compounds applying its proprietary Eligen technology in the US. The Eligen technology can be applied to the oral route of administration, as well as to other delivery pathways, such as inhalation, buccal, transdermal, intra-vaginal, rectal or facilitate in the transport of therapeutic macromolecules such as proteins, peptides, and polysaccharides, and poorly absorbed small molecules across biological membranes, such as the small intestine.
Emisphere Technologies, Inc. Key Recent Developments
Mar 28, 2013: Emisphere Technologies Reports 2012 Results
Nov 13, 2012: Emisphere Technologies Reports Q3 2012 Results
Sep 17, 2012: Emisphere Technologies Appoints Alan Rubino As CEO
Aug 07, 2012: Emisphere Technologies Reports Q2 2012 Results
May 09, 2012: Emisphere Technologies Reports Q1 2012 Results
This comprehensive SWOT profile of Emisphere Technologies, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
Emisphere Technologies, Inc. - Key Facts
Emisphere Technologies, Inc. - Key Employees
Emisphere Technologies, Inc. - Key Employee Biographies
Emisphere Technologies, Inc. - Major Products and Services
Emisphere Technologies, Inc. - Pharmaceutical Pipeline Products Data
Emisphere Technologies, Inc., Pipeline Products by Therapy Area
Emisphere Technologies, Inc., Pipeline Products by Development Phase
Emisphere Technologies, Inc. - History
Emisphere Technologies, Inc. - Company Statement
Emisphere Technologies, Inc. - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Emisphere Technologies, Inc. - Business Description
Emisphere Technologies, Inc. - Corporate Strategy
Emisphere Technologies, Inc. - SWOT Analysis
SWOT Analysis - Overview
Emisphere Technologies, Inc. - Strengths
Strength - Proprietary Drug Delivery Technology
Strength - Broad Patent Portfolio
Emisphere Technologies, Inc. - Weaknesses
Weakness - Lack of Product Based Revenues
Emisphere Technologies, Inc. - Opportunities
Opportunity - Strategic Agreements and Collaborations
Opportunity - Changing Demographics
Opportunity - Rising Healthcare Expenditure in US
Emisphere Technologies, Inc. - Threats
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Threat - Intense Competition
Emisphere Technologies, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Emisphere Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Emisphere Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Emisphere Technologies, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Emisphere Technologies, Inc., Recent Developments
Mar 28, 2013: Emisphere Technologies Reports 2012 Results
Nov 13, 2012: Emisphere Technologies Reports Q3 2012 Results
Sep 17, 2012: Emisphere Technologies Appoints Alan Rubino As CEO
Aug 07, 2012: Emisphere Technologies Reports Q2 2012 Results
May 09, 2012: Emisphere Technologies Reports Q1 2012 Results
Mar 21, 2012: Emisphere Technologies Reports Q4 2011 Results
Mar 01, 2012: Emisphere Announces Appointments To Board
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer
List of Tables
Emisphere Technologies, Inc., Key Facts
Emisphere Technologies, Inc., Key Employees
Emisphere Technologies, Inc., Key Employee Biographies
Emisphere Technologies, Inc., Major Products and Services
Emisphere Technologies, Inc., Number of Pipeline Products by Therapy Area
Emisphere Technologies, Inc., Number of Pipeline Products by Development Stage
Emisphere Technologies, Inc., Pipeline Products By Therapy Area and Development Phase
Emisphere Technologies, Inc., History
Emisphere Technologies, Inc., Key Competitors
Emisphere Technologies, Inc., Ratios based on current share price
Emisphere Technologies, Inc., Annual Ratios
Emisphere Technologies, Inc., Interim Ratios
Emisphere Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Emisphere Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Emisphere Technologies, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Emisphere Technologies, Inc., Pipeline Products by Therapy Area
Emisphere Technologies, Inc., Pipeline Products by Development Phase
Emisphere Technologies, Inc., Performance Chart (2007 - 2011)
Emisphere Technologies, Inc., Ratio Charts
Emisphere Technologies, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Emisphere Technologies, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Genta Incorporated
pSivida Corp.
Nektar Therapeutics
Alkermes, Inc.
Eli Lilly and Company
GlaxoSmithKline plc
Bristol-Myers Squibb Company
Unigene Laboratories, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
